Pilgrim's Pride Corporation
PPCPilgrim's Pride Corporation's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
The sharpest disagreement: annual EPS moved −0.3% against a −43.8% price move — the market has not yet caught up with the delivery.
The price is in a downtrend (23 weeks in). Underneath, the last four quarters read deteriorating — profit −66.7% year on year, and 162% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Pilgrim's Pride Corporation trades at $27.0, in a downtrend and 23 weeks into that stage. That is −23.9% against its own 200-day average. It sits at 0% of a 52-week range of $27 to $48. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (19 weeks and counting).
Today the stock is in a downtrend — week 23 of stage 4. At $27.0 it trades −23.9% versus its 200-day average and sits at 0% of its 52-week range ($27–$48).
Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved +5% while the S&P 500 moved +263% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (19 weeks and counting; last ahead the week of 2026-03-27) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
Pilgrim's Pride Corporation trades at 11.8× P/E, against too little history to rank. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 11.8× is against too little history to rank. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved −0.3% against a −43.8% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 3y, of the +2.2%/yr price move, ~+75.5%/yr came from earnings growth and ~−73.3 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Deteriorating Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Pilgrim's Pride Corporation reads as deteriorating on its fundamental arc. Deteriorating — profit and EPS growth are shrinking (profit growth −27.0% latest against +3166.7% at its 12-quarter best), ROCE slipping at 18.8%. The read is built from 12 quarters across 4 curves, on full evidence.
🚨 Why it matters: falling curves mean every cheap-looking ratio below needs a discount for direction.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +3.5% | +1.9% | — | — |
| Profit | −0.9% | +12.9% | — | — |
| EPS | −0.3% | +13.7% | — | — |
| Stock price | −43.8% | +2.2% | +4.8% | +1.6% |
4-Factor Sector Score
33.7/100 — rank 23 of 30 in Packaged Foods · 56% evidence confidence
Pilgrim's Pride Corporation scores 33.7 out of 100 against the 30 companies it is compared with in Packaged Foods, ranking 23. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 12.8 + 8.7 + 10.2 + 2 = 33.7. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Pilgrim's Pride Corporation reported $4.5 B of revenue in the Mar 26 quarter, +1.6% year on year. That is the 5th straight quarter of year-on-year growth. Over 4 years it has compounded at 5.8% a year. The last full year, FY25, came in at $18.5 B. The last four reported quarters add to $18.6 B.
FY25 revenue came in at $18.5 B (+3.5% on the year), capping 4 years at 5.8% compound. The latest quarter (Mar 26) printed $4.5 B, +1.6% year on year — the 5th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +3.3% growth against the decade's 5.8% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +3.3% over the last 4 quarters against +2.8%/yr over the last 8 — stabilising; TTM profit −27.0% vs +36.2%/yr — rolling over.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Pilgrim's Pride Corporation's operating margin is 3.5% in the Mar 26 quarter, −5.5 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 5 fiscal years the operating margin has ranged 1.4% to 8.7%. The current quarter sits inside that band.
The latest quarter's operating margin is 3.5%, −5.5 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 1.4%–8.7%, and FY25's 8.7% is the top of that band — a record year.
🚨 Why the margin moved: operating margin went −5.5 pp year on year while gross margin went −4.6 pp — the loss came mostly from the gross line: input costs and pricing.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Pilgrim's Pride Corporation earned $0.1 B of net profit in the Mar 26 quarter, −66.7% year on year. Full-year FY25 profit was $1.1 B. The 4-year compound rate is 144.9%. That is 2.2% of the quarter's revenue. The same quarter a year earlier earned $0.3 B.
Mar 26 profit was $0.1 B, −66.7% year on year. On the full year, FY25 printed $1.1 B (−0.9%), and the 4-year compound rate is 144.9%.
🚨 Why profit moved: revenue contributed +1.6% and the margin −5.5 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit −30.8% vs revenue +3.3%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 162% of Pilgrim's Pride Corporation's reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $1.4 B of operating cash against $1.1 B of profit. After $0.7 B of capital spending, $0.7 B was left as free cash.
FY25: operating cash of $1.4 B against reported profit of $1.1 B, leaving free cash of $0.7 B after $0.7 B of capital spending. Across the last 3 fiscal years the conversion rate is 162% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Pilgrim's Pride Corporation does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $2.0 B over the last 3 years. Averaged over those years that is 3.6% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $2.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Pilgrim's Pride Corporation earns a ROE of 29% in FY25. That is up from a trough of 1% in FY21. Return on invested capital clears the cost of that capital by +8.5 percentage points, so growth here adds value rather than only size. The wiring behind it is 5.8% net margin on 1.79× asset turns.
FY25 ROE is 29%, recovered from a FY21 trough of 1% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY25): 5.8% net margin × 1.79× asset turns × 2.80× balance-sheet leverage ≈ 29.1% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 13.7% − 5.2% = a +8.5 pp spread. The 5.2% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. A spread this wide means every dollar reinvested creates more than a dollar of value — the engine compounds.
Dividend
Pilgrim's Pride Corporation pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.
Pilgrim's Pride Corporation does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Pilgrim's Pride Corporation carries total debt of $3.0 B against shareholder equity of $3.8 B as of Jun 26, a debt-to-equity of 0.81. On the annual view that ratio went from 1.35 in FY21 to 0.89 in FY25. Read the returns elsewhere on this page with that leverage in mind.
Jun 26: total debt of $3.0 B against shareholder equity of $3.8 B — a debt-to-equity of 0.81. On the annual view, debt-to-equity went from 1.35 (FY21) to 0.89 (FY25). Read the returns on this page with that leverage in mind.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
18.3% of Pilgrim's Pride Corporation's tradable float is currently sold short — a large bloc is positioned against it. At typical trading volumes those positions would take about 4.6 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 18.3% of the float is sold short, and at typical trading volumes it would take about 4.6 days to buy those positions back. A large bloc is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Pilgrim's Pride Corporation: the Z-score reads 3.59. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 3.59 sits well clear of the distress zone — the balance sheet is not the risk here.
The safety line in one sentence: the Z-score reads 3.59.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Seneca Foods CorporationSENEA | 65.4/100Thin evidence · provisional60% evidence | TURNING | 22.9/35 Revenue 5.1% · PAT 100% · OPM change 5.4 pp 53% evidence | 10.8/25 ROCE 2.3% · OPM 6% 57% evidence | 15.7/20 P/E 9.1× · PEG 0.28 65% evidence | 16.0/20 RS sector 25.6% · RS bench 18.5% · 1Y 69%5 of 12 weeks ahead 70% evidence |
| Exact sum: 22.9 + 10.8 + 15.7 + 16 = 65.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 2Darling Ingredients Inc.DAR | 62.8/100Thin evidence · provisional56% evidence | ASLEEP | 23.2/35 Revenue — · PAT — · OPM change 9.5 pp 39% evidence | 17.1/25 ROCE 12% · OPM 14.6% 76% evidence | 9.8/20 P/E 15.2× · PEG — 15% evidence | 12.7/20 RS sector 22.3% · RS bench 16.1% · 1Y 96.4%1 of 12 weeks ahead 100% evidence |
| Exact sum: 23.2 + 17.1 + 9.8 + 12.7 = 62.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 3Central Garden & Pet CompanyCENT | 62.5/100Mixed-positive evidence66% evidence | BREAKING OUT | 19.7/35 Revenue 0.2% · PAT 37.9% · OPM change 0.8 pp 53% evidence | 13.6/25 ROCE 8.8% · OPM 12.6% 57% evidence | 15.1/20 P/E 12.1× · PEG 0.25 65% evidence | 14.1/20 RS sector 15.4% · RS bench 8.4% · 1Y 29.3%7 of 12 weeks ahead 100% evidence |
| Exact sum: 19.7 + 13.6 + 15.1 + 14.1 = 62.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Mama's Creations, Inc.MAMA | 59.9/100Mixed-positive evidence81% evidence | BREAKING OUT | 24.5/35 Revenue 46.5% · PAT 50% · OPM change 0.5 pp 83% evidence | 11.3/25 ROCE 5.3% · OPM 5% 76% evidence | 5.6/20 P/E 94.6× · PEG 2.6 65% evidence | 18.5/20 RS sector 30.7% · RS bench 23.5% · 1Y 135.2%8 of 12 weeks ahead 100% evidence |
| Exact sum: 24.5 + 11.3 + 5.6 + 18.5 = 59.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5The J. M. Smucker CompanySJM | 59.7/100Mixed-positive evidence64% evidence | BREAKING OUT | 22.5/35 Revenue 3.7% · PAT — · OPM change 47.5 pp 62% evidence | 12.9/25 ROCE 3.1% · OPM 19.6% 76% evidence | 9.1/20 P/E 23× · PEG — 15% evidence | 15.2/20 RS sector 7.9% · RS bench 0.9% · 1Y 7.6%7 of 12 weeks ahead 100% evidence |
| Exact sum: 22.5 + 12.9 + 9.1 + 15.2 = 59.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6John B. Sanfilippo & Son, Inc.JBSS | 58.8/100Thin evidence · provisional60% evidence | TURNING | 16.6/35 Revenue 5.1% · PAT 21.4% · OPM change -2.4 pp 53% evidence | 13.8/25 ROCE 5.2% · OPM 8.4% 57% evidence | 13.9/20 P/E 13.6× · PEG 0.67 65% evidence | 14.5/20 RS sector 8.5% · RS bench 2% · 1Y 34%0 of 12 weeks ahead 70% evidence |
| Exact sum: 16.6 + 13.8 + 13.9 + 14.5 = 58.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7The Campbell's CompanyCPB | 56.0/100Mixed-positive evidence81% evidence | TURNING | 22.1/35 Revenue -2.9% · PAT 33.9% · OPM change 3.6 pp 83% evidence | 11.8/25 ROCE 2% · OPM 10.1% 76% evidence | 15.2/20 P/E 10.3× · PEG 0.3 65% evidence | 6.9/20 RS sector -16.8% · RS bench -23.1% · 1Y -29.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 22.1 + 11.8 + 15.2 + 6.9 = 56 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Smithfield Foods, Inc.SFD | 51.3/100Mixed-positive evidence66% evidence | BASING | 17.4/35 Revenue 7.5% · PAT 12.1% · OPM change 0.3 pp 53% evidence | 13.4/25 ROCE 3.1% · OPM 8.8% 57% evidence | 13.5/20 P/E 10.4× · PEG 0.96 65% evidence | 7.0/20 RS sector -0.8% · RS bench -7% · 1Y -0.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.4 + 13.4 + 13.5 + 7 = 51.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Lamb Weston Holdings, Inc.LW | 50.6/100Thin evidence · provisional56% evidence | TURNING | 14.9/35 Revenue — · PAT — · OPM change -8.3 pp 39% evidence | 12.0/25 ROCE 2.8% · OPM 8.1% 76% evidence | 9.5/20 P/E 20.8× · PEG — 15% evidence | 14.2/20 RS sector 2.4% · RS bench -4.8% · 1Y 3.2%3 of 12 weeks ahead 100% evidence |
| Exact sum: 14.9 + 12 + 9.5 + 14.2 = 50.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 10Utz Brands, Inc.UTZ | 50.4/100Thin evidence · provisional56% evidence | TURNING | 14.7/35 Revenue 2.3% · PAT -144.1% · OPM change 0.6 pp 53% evidence | 7.3/25 ROCE 0.3% · OPM 2.2% 57% evidence | 8.5/20 P/E 1046× · PEG — 15% evidence | 19.9/20 RS sector 37.4% · RS bench 27% · 1Y 10.5%3 of 12 weeks ahead 100% evidence |
| Exact sum: 14.7 + 7.3 + 8.5 + 19.9 = 50.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 11JBS N.V.JBS | 47.6/100Thin evidence · provisional60% evidence | BASING | 15.5/35 Revenue 12.1% · PAT -11.3% · OPM change -2.3 pp 53% evidence | 9.6/25 ROCE 1.5% · OPM 2.2% 57% evidence | 15.5/20 P/E 11.3× · PEG 0.16 65% evidence | 7.0/20 RS sector -9.9% · RS bench -16% · 1Y -4.8%0 of 12 weeks ahead 70% evidence |
| Exact sum: 15.5 + 9.6 + 15.5 + 7 = 47.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 12The Kraft Heinz CompanyKHC | 47.0/100Thin evidence · provisional56% evidence | TURNING | 13.4/35 Revenue -1.8% · PAT -317% · OPM change -1 pp 53% evidence | 11.4/25 ROCE 1.5% · OPM 18.9% 57% evidence | 9.9/20 P/E 13.8× · PEG — 15% evidence | 12.3/20 RS sector 4.2% · RS bench -2.7% · 1Y -4%4 of 12 weeks ahead 100% evidence |
| Exact sum: 13.4 + 11.4 + 9.9 + 12.3 = 47 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13Hormel Foods CorporationHRL | 46.3/100Mixed-negative evidence71% evidence | BREAKING OUT | 13.1/35 Revenue 2.5% · PAT -37.6% · OPM change -1.3 pp 83% evidence | 10.7/25 ROCE 1.8% · OPM 7.3% 76% evidence | 8.9/20 P/E 25.4× · PEG — 15% evidence | 13.6/20 RS sector 2% · RS bench -4.9% · 1Y -11%5 of 12 weeks ahead 100% evidence |
| Exact sum: 13.1 + 10.7 + 8.9 + 13.6 = 46.3 · Decision use: Price leads the evidence: RS versus the benchmark is -4.9%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 14Ingredion IncorporatedINGR | 45.4/100Mixed-negative evidence66% evidence | BASING | 14.4/35 Revenue -2.2% · PAT 7.2% · OPM change -3.9 pp 53% evidence | 14.0/25 ROCE 3.1% · OPM 11.3% 57% evidence | 12.5/20 P/E 10.9× · PEG 1.14 65% evidence | 4.5/20 RS sector -10.3% · RS bench -16.5% · 1Y -17.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 14.4 + 14 + 12.5 + 4.5 = 45.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15McCormick & Company, IncorporatedMKC | 45.3/100Mixed-negative evidence81% evidence | TURNING | 18.4/35 Revenue 9.5% · PAT 1.1% · OPM change -0.5 pp 83% evidence | 14.2/25 ROCE 2.4% · OPM 14.3% 76% evidence | 6.7/20 P/E 7.9× · PEG 4.94 65% evidence | 6.0/20 RS sector -16.9% · RS bench -23% · 1Y -26%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.4 + 14.2 + 6.7 + 6 = 45.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16BellRing Brands, Inc.BRBR | 45.3/100Thin evidence · provisional60% evidence | TURNING | 13.0/35 Revenue 6.4% · PAT -43.6% · OPM change -5.2 pp 53% evidence | 15.5/25 ROCE 9.2% · OPM 11% 57% evidence | 13.8/20 P/E 12.5× · PEG 0.7 65% evidence | 3.0/20 RS sector -45.3% · RS bench -50.3% · 1Y -67.3%1 of 12 weeks ahead 70% evidence |
| Exact sum: 13 + 15.5 + 13.8 + 3 = 45.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17Freshpet, Inc.FRPT | 45.1/100Mixed-negative evidence61% evidence | TURNING | 20.5/35 Revenue 12.1% · PAT 100% · OPM change 5.9 pp 40% evidence | 6.9/25 ROCE 0.3% · OPM 1.5% 57% evidence | 5.3/20 P/E 15.8× · PEG 2.98 65% evidence | 12.4/20 RS sector 0% · RS bench -6.8% · 1Y -0.6%1 of 12 weeks ahead 100% evidence |
| Exact sum: 20.5 + 6.9 + 5.3 + 12.4 = 45.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Nomad Foods LimitedNOMD | 43.7/100Thin evidence · provisional60% evidence | BREAKING OUT | 13.3/35 Revenue -2.9% · PAT -40.9% · OPM change -1.8 pp 53% evidence | 10.3/25 ROCE 1.1% · OPM 7.9% 57% evidence | 11.5/20 P/E 9.3× · PEG 1.49 65% evidence | 8.6/20 RS sector -2.1% · RS bench -9.2% · 1Y -26.3%6 of 12 weeks ahead 70% evidence |
| Exact sum: 13.3 + 10.3 + 11.5 + 8.6 = 43.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19The Marzetti CompanyMZTI | 40.7/100Mixed-negative evidence66% evidence | BASING | 15.8/35 Revenue 2.8% · PAT 3.5% · OPM change -0.6 pp 53% evidence | 13.4/25 ROCE 4.1% · OPM 10.3% 57% evidence | 8.7/20 P/E 21.6× · PEG 1.71 65% evidence | 2.8/20 RS sector -28.7% · RS bench -34.2% · 1Y -38.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 15.8 + 13.4 + 8.7 + 2.8 = 40.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Conagra Brands, Inc.CAG | 39.8/100Thin evidence · provisional56% evidence | TURNING | 15.5/35 Revenue — · PAT — · OPM change 1.6 pp 39% evidence | 6.8/25 ROCE -10.8% · OPM 10% 76% evidence | 10.6/20 P/E 11.2× · PEG — 15% evidence | 6.9/20 RS sector -13.1% · RS bench -19.4% · 1Y -22.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 15.5 + 6.8 + 10.6 + 6.9 = 39.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 21Post Holdings, Inc.POST | 38.8/100Mixed-negative evidence66% evidence | BASING | 18.5/35 Revenue 7.2% · PAT -5% · OPM change 1.1 pp 53% evidence | 11.6/25 ROCE 1.8% · OPM 10.4% 57% evidence | 5.6/20 P/E 16.6× · PEG 2.92 65% evidence | 3.1/20 RS sector -13.8% · RS bench -19.6% · 1Y -16.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.5 + 11.6 + 5.6 + 3.1 = 38.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Flowers Foods, Inc.FLO | 38.3/100Thin evidence · provisional56% evidence | ASLEEP | 16.9/35 Revenue — · PAT — · OPM change -0.4 pp 39% evidence | 10.1/25 ROCE 2.3% · OPM 5.1% 76% evidence | 9.4/20 P/E 21.5× · PEG — 15% evidence | 1.9/20 RS sector -31.3% · RS bench -36.7% · 1Y -55.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.9 + 10.1 + 9.4 + 1.9 = 38.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 23Pilgrim's Pride Corporationthis pagePPC | 33.7/100Thin evidence · provisional56% evidence | BASING | 12.8/35 Revenue — · PAT — · OPM change -5.5 pp 39% evidence | 8.7/25 ROCE 0.9% · OPM 3.6% 76% evidence | 10.2/20 P/E 12.5× · PEG — 15% evidence | 2.0/20 RS sector -29.2% · RS bench -34.5% · 1Y -46%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.8 + 8.7 + 10.2 + 2 = 33.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 24J&J Snack Foods Corp.JJSF | 33.4/100Thin evidence · provisional60% evidence | BASING | 14.6/35 Revenue -2.1% · PAT -23.7% · OPM change -1.2 pp 53% evidence | 9.0/25 ROCE 0.2% · OPM 0.5% 57% evidence | 3.8/20 P/E 26.8× · PEG 6.43 65% evidence | 6.0/20 RS sector -13.2% · RS bench -19.5% · 1Y -28.1%0 of 12 weeks ahead 70% evidence |
| Exact sum: 14.6 + 9 + 3.8 + 6 = 33.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 25General Mills, Inc.GIS | 27.7/100Adverse evidence71% evidence | BASING | 5.8/35 Revenue -5.4% · PAT -103.7% · OPM change -56.5 pp 83% evidence | 6.5/25 ROCE -8.6% · OPM -45.4% 76% evidence | 10.7/20 P/E 10.9× · PEG — 15% evidence | 4.7/20 RS sector -17.9% · RS bench -24% · 1Y -27.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 5.8 + 6.5 + 10.7 + 4.7 = 27.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26The Simply Good Foods CompanySMPL | 23.6/100Adverse evidence65% evidence | ASLEEP | 5.4/35 Revenue -4.5% · PAT -237.2% · OPM change -29.6 pp 83% evidence | 5.7/25 ROCE -2.3% · OPM -14% 76% evidence | 9.2/20 P/E 21.9× · PEG — 15% evidence | 3.3/20 RS sector -38.1% · RS bench -43.3% · 1Y -61.5%1 of 12 weeks ahead 70% evidence |
| Exact sum: 5.4 + 5.7 + 9.2 + 3.3 = 23.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27Westrock Coffee CompanyWEST | 52.8/100Thin evidence · provisional48% evidence | ASLEEP | 21.7/35 Revenue 47.3% · PAT — · OPM change 7.1 pp 40% evidence | 7.1/25 ROCE 0.4% · OPM 1% 57% evidence | 10.0/20 P/E — · PEG — 0% evidence | 14.0/20 RS sector 34.5% · RS bench 27.8% · 1Y 14.2%11 of 12 weeks ahead 100% evidence |
| Exact sum: 21.7 + 7.1 + 10 + 14 = 52.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 28Herbalife Ltd.HLF | 51.3/100Thin evidence · provisional50% evidence | ASLEEP | 17.6/35 Revenue 3.7% · PAT -15% · OPM change 0.4 pp 53% evidence | 14.8/25 ROCE 8.1% · OPM 10.5% 57% evidence | 11.5/20 P/E 6.5× · PEG — 15% evidence | 7.4/20 RS sector -4.9% · RS bench -10.8% · 1Y 43.8%0 of 12 weeks ahead 70% evidence |
| Exact sum: 17.6 + 14.8 + 11.5 + 7.4 = 51.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 29Once Upon A Farm, PBCOFRM | 45.1/100Thin evidence · provisional28% evidence | FADING | 19.6/35 Revenue 48.6% · PAT — · OPM change -4 pp 40% evidence | 5.5/25 ROCE -15.8% · OPM -22.2% 57% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y —4 of 12 weeks ahead 0% evidence |
| Exact sum: 19.6 + 5.5 + 10 + 10 = 45.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 30The Magnum Ice Cream Company N.V.MICC | 44.6/100Thin evidence · provisional18% evidence | BREAKING OUT | 16.7/35 Revenue — · PAT — · OPM change — 9% evidence | 9.2/25 ROCE 0.4% · OPM — 46% evidence | 8.7/20 P/E 28.1× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —6 of 12 weeks ahead 0% evidence |
| Exact sum: 16.7 + 9.2 + 8.7 + 10 = 44.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Pilgrim's Pride Corporation's stock price today?
Pilgrim's Pride Corporation trades at $27.0, −43.8% over the past year. The company is valued at $6.0 B. The stock sits at 0% of its 52-week range of $27–$48, −23.9% versus its 200-day average. On the tape, the price is in a downtrend, 23 weeks in. — as of 5 August 2026.
What were Pilgrim's Pride Corporation's latest quarterly results?
Pilgrim's Pride Corporation reported revenue of $4.5 B and net profit of $0.1 B for the Mar 26 quarter. Revenue rose 1.6% and profit fell 66.7% year on year. Earnings per share were $0.43. The operating margin was 3.5%, 5.5 pp lower than a year earlier. — as of 5 August 2026.
What is Pilgrim's Pride Corporation's revenue?
Pilgrim's Pride Corporation reported revenue of $4.5 B in the Mar 26 quarter, +1.6% year on year. For the full FY25 fiscal year, revenue was $18.5 B (+3.5%). Over the last 4 years revenue compounded at 5.8% a year. — as of 5 August 2026.
What is Pilgrim's Pride Corporation's profit?
Pilgrim's Pride Corporation earned $0.1 B of net profit in the Mar 26 quarter, −66.7% year on year. Full-year FY25 profit was $1.1 B. The operating margin ran 3.5% in the latest quarter. — as of 5 August 2026.
What is Pilgrim's Pride Corporation's market cap?
Pilgrim's Pride Corporation's market capitalisation is $6.0 B at a stock price of $27.0. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
Does Pilgrim's Pride Corporation pay a dividend?
No — Pilgrim's Pride Corporation has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.
Is Pilgrim's Pride Corporation growing?
Not right now — Pilgrim's Pride Corporation's latest numbers are shrinking: latest-quarter revenue +1.6% year on year, profit −66.7%, and the margin −5.5 pp at 3.5%. The 4-year compound rates are 5.8% (revenue) and 144.9% (profit). The earnings engine currently reads: deteriorating — as of 5 August 2026.
How is Pilgrim's Pride Corporation performing?
Pilgrim's Pride Corporation is in a downtrend, 23 weeks in. Its latest quarter's revenue rose 1.6% and profit fell 66.7% year on year. Against the S&P 500 it has been behind on a trailing-13-week view for 19 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
What stage is Pilgrim's Pride Corporation in?
Deteriorating — profit and EPS growth are shrinking (profit growth −27.0% latest against +3166.7% at its 12-quarter best), ROCE slipping at 18.8%. The read comes from the last 12 quarters of growth (revenue growth +3.3% latest, profit growth −27.0% latest, eps growth −26.5% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.
Is Pilgrim's Pride Corporation in an uptrend?
No — the price is in a downtrend (week 23 of stage 4), trading −23.9% versus its 200-day average and at 0% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.
Is Pilgrim's Pride Corporation beating the market?
Not lately — on a trailing-13-week view Pilgrim's Pride Corporation is currently behind the S&P 500 (19 weeks and counting; last ahead the week of 2026-03-27), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved +5% against the S&P 500's +263% — behind the index over the full window. — as of 5 August 2026.
Will Pilgrim's Pride Corporation's stock price go up?
This page publishes no price forecast for Pilgrim's Pride Corporation. What it measures instead: the stock price is $27.0, the price is in a downtrend 23 weeks in. Direction is not something this site claims to know. — as of 5 August 2026.
Is the market betting against Pilgrim's Pride Corporation?
Yes — short interest is 18.3% of Pilgrim's Pride Corporation's tradable float, about 4.6 days to cover at typical volumes. A crowded short: a large bloc is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.
Does Pilgrim's Pride Corporation have too much debt?
It is moderate — Pilgrim's Pride Corporation's debt-to-equity is 0.83. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 5 August 2026.
What is Pilgrim's Pride Corporation's capex?
Pilgrim's Pride Corporation spent $2.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.7 B. — as of 5 August 2026.
What is Pilgrim's Pride Corporation's cash flow?
Pilgrim's Pride Corporation generated $1.4 B of operating cash flow in FY25 and $0.7 B of free cash flow after $0.7 B of capital spending. Reported profit that year was $1.1 B, so operating cash ran ahead of profit. — as of 5 August 2026.
Is Pilgrim's Pride Corporation's profit real cash?
Yes — over the last 3 fiscal years, 162% of Pilgrim's Pride Corporation's reported profit arrived as operating cash. In FY25, operating cash was $1.4 B against reported profit of $1.1 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.
How financially safe is Pilgrim's Pride Corporation?
On the balance sheet, the Z-score reads 3.59 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 5 August 2026.
Where is Pilgrim's Pride Corporation in its business cycle?
Pilgrim's Pride Corporation's FY25 operating margin was 8.7%, against a 5-year band of 1.4%–8.7%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 3.5%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the Pilgrim's Pride Corporation story?
The sharpest disagreement: annual EPS moved −0.3% against a −43.8% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is Pilgrim's Pride Corporation a stock worth studying right now?
This is not investment advice. The machine read: Pilgrim's Pride Corporation's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.